Union Of India vs M/S. Ranbaxy Laboratories Ltd. & Ors

The Supreme Court addressed the interpretation of the Drugs (Price Control) Order, 1995, and the Essential Commodities Act, 1955, particularly focusing on the obligations of pharmaceutical manufacturers regarding price fixation after the expiry of exemptions. The Court held that manufacturers must adhere to existing notified prices upon exemption expiry, and failure to comply can result in recovery actions under Section 10 of the 1955 Act. The judgment emphasized the necessity for compliance with regulatory price controls to ensure fair pricing in the pharmaceutical industry.